Grifols Gross Profit 2012-2018 | GRFS

Grifols annual/quarterly gross profit history and growth rate from 2012 to 2018. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Grifols gross profit for the quarter ending September 30, 2018 was $0.000B, a 100% decline year-over-year.
  • Grifols gross profit for the twelve months ending September 30, 2018 was $1.812B, a 14.37% decline year-over-year.
  • Grifols annual gross profit for 2017 was $2.432B, a 14.95% increase from 2016.
  • Grifols annual gross profit for 2016 was $2.116B, a 1.31% decline from 2015.
  • Grifols annual gross profit for 2015 was $2.144B, a 5.07% decline from 2014.
Grifols Annual Gross Profit
(Millions of US $)
2017 $2,432
2016 $2,116
2015 $2,144
2014 $2,259
2013 $1,883
2012 $1,710
2011 $1,900
Grifols Quarterly Gross Profit
(Millions of US $)
Q3 2018 $0
Q2 2018 $617
Q2 2017 $617
Q1 2017 $578
Q4 2016 $543
Q3 2016 $522
Q2 2016 $528
Q1 2016 $523
Q4 2015 $572
Q3 2015 $537
Q2 2015 $526
Q1 2015 $506
Q4 2014 $442
Q3 2014 $567
Q2 2014 $532
Q1 2014 $594
Q4 2013 $456
Q3 2013 $471
Q2 2013 $485
Q1 2013 $462
Q4 2012 $421
Q3 2012 $418
Q2 2012 $430
Q1 2012 $423
Q4 2011 $796
Q3 2011 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.559B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.440B 30.23
Takeda Pharmaceutical (TAK) Japan $31.638B 11.70
Ionis Pharmaceuticals (IONS) United States $8.053B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.660B 10.99
Nektar Therapeutics (NKTR) United States $7.410B 10.62
Neurocrine Biosciences (NBIX) United States $7.347B 475.82
Tilray (TLRY) United States $7.176B 0.00
Sage Therapeutics (SAGE) United States $7.171B 0.00
Catalent (CTLT) United States $6.152B 25.76
United Therapeutics (UTHR) United States $5.177B 8.47
FibroGen (FGEN) United States $4.896B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.183B 22.24
Taro Pharmaceutical Industries (TARO) Israel $4.119B 13.26
USANA Health Sciences (USNA) United States $2.535B 20.69
Endo (ENDP) Ireland $2.403B 3.68
Ironwood Pharmaceuticals (IRWD) United States $2.251B 0.00
Heron Therapeutics (HRTX) United States $2.137B 0.00
Portola Pharmaceuticals (PTLA) United States $2.081B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.067B 0.00
Xencor (XNCR) United States $2.029B 0.00
Zogenix (ZGNX) United States $1.994B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.968B 24.51
Aerie Pharmaceuticals (AERI) United States $1.855B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.708B 0.00
PTC Therapeutics (PTCT) United States $1.707B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.642B 221.89
Theravance Biopharma (TBPH) Cayman Islands $1.491B 0.00
TherapeuticsMD (TXMD) United States $1.425B 0.00
Corcept Therapeutics (CORT) United States $1.324B 19.44
Spectrum Pharmaceuticals (SPPI) United States $1.253B 0.00
Esperion Therapeutics (ESPR) United States $1.167B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.979B 0.00
Tricida (TCDA) United States $0.964B 0.00
Radius Health (RDUS) United States $0.844B 0.00
ImmunoGen (IMGN) United States $0.824B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.587B 0.00
Siga Technologies (SIGA) United States $0.566B 0.00
Karyopharm Therapeutics (KPTI) United States $0.557B 0.00
ChemoCentryx (CCXI) United States $0.547B 43.28
Flexion Therapeutics (FLXN) United States $0.542B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.530B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.520B 30.69
GlycoMimetics (GLYC) United States $0.502B 0.00
Collegium Pharmaceutical (COLL) United States $0.500B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.493B 0.00
Forty Seven (FTSV) United States $0.468B 0.00
Odonate Therapeutics (ODT) United States $0.447B 0.00
Aptorum Group (APM) China $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.398B 0.00
Lannett Co Inc (LCI) United States $0.375B 3.49
Translate Bio (TBIO) United States $0.375B 0.00
Akebia Therapeutics (AKBA) United States $0.374B 0.00
HARPOON THERAPT (HARP) United States $0.361B 0.00
CASI Pharmaceuticals (CASI) United States $0.359B 0.00
ArQule (ARQL) United States $0.353B 0.00
Concert Pharmaceuticals (CNCE) United States $0.353B 0.00
KalVista Pharmaceuticals (KALV) United States $0.349B 0.00
Tyme Technologies (TYME) United States $0.329B 0.00
Dermira (DERM) United States $0.320B 0.00
Minerva Neurosciences (NERV) United States $0.303B 0.00
OptiNose (OPTN) United States $0.301B 0.00
Majesco Entertainment (PTE) United States $0.297B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.286B 10.67
Verrica Pharmaceuticals (VRCA) United States $0.285B 0.00
Aclaris Therapeutics (ACRS) United States $0.282B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.280B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.263B 0.00
Mast Therapeutics (SVRA) United States $0.239B 0.00
Opexa Therapeutics (ACER) United States $0.233B 0.00
Dova Pharmaceuticals (DOVA) United States $0.232B 0.00
IMV INC (IMV) Canada $0.220B 0.00
Affimed (AFMD) Germany $0.215B 0.00
Aratana Therapeutics (PETX) United States $0.214B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Rafael Holdings (RFL) United States $0.214B 0.00
Xeris Pharmaceuticals (XERS) United States $0.209B 0.00
MEI Pharma (MEIP) United States $0.206B 0.00
Calithera Biosciences (CALA) United States $0.204B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.200B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.196B 0.00
ElectroCore (ECOR) United States $0.195B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.191B 0.00
Recro Pharma (REPH) United States $0.186B 0.00
Redhill Biopharma (RDHL) Israel $0.177B 0.00
Molecular Templates (MTEM) United States $0.176B 0.00
AgeX Therapeutics (AGE) United States $0.172B 0.00
Zafgen (ZFGN) United States $0.168B 0.00
Nature's Sunshine Products (NATR) United States $0.165B 0.00
Aquestive Therapeutics (AQST) United States $0.164B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.158B 0.00
Ocular Therapeutix (OCUL) United States $0.153B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.152B 0.00
Adherex Technologies (FENC) United States $0.149B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.137B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
Neon Therapeutics (NTGN) United States $0.131B 0.00
MediWound (MDWD) Israel $0.131B 0.00
Cardiome Pharma (CORV) Canada $0.129B 0.00
DURECT (DRRX) United States $0.127B 0.00
ProNAi Therapeutics (SRRA) Canada $0.126B 0.00
China SXT Pharmaceuticals (SXTC) China $0.120B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.107B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 0.00
Natural Alternatives (NAII) United States $0.084B 8.17
Nivalis Therapeutics (ALPN) United States $0.082B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.081B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.078B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
Melinta Therapeutics (MLNT) United States $0.069B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.067B 0.00
Immune Design (IMDZ) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.065B 0.00
Avenue Therapeutics (ATXI) United States $0.063B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.062B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.062B 0.00
Otonomy (OTIC) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
KemPharm (KMPH) United States $0.061B 0.00
Forward Pharma (FWP) Denmark $0.060B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Genocea Biosciences (GNCA) United States $0.045B 0.00
Achaogen (AKAO) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Lipocine (LPCN) United States $0.036B 0.00
Capnia (SLNO) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
NOVAN INC (NOVN) United States $0.031B 0.00
NanoViricides (NNVC) United States $0.030B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Trillium Therapeutics (TRIL) Canada $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Shineco (TYHT) China $0.012B 1.32
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Intellipharmaceutics (IPCI) Canada $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00